✦ LIBER ✦

Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704

✍ Scribed by J. Skillings; F. LaFleur; N. Leighl; J. Bennouna; H.-P. Kuo; B. Szima; M. Gottfried; A. Kunitsyn; J.M. Trigo; G.-C. Chang; J. Cosaert; C. Manegold

Book ID: 114412060
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 450 KB
Volume: 8
Category: Article
ISSN: 1525-7304
DOI: 10.1016/s1525-7304(11)70819-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6610 POSTER Safety of bevacizumab treatm

6610 POSTER Safety of bevacizumab treatment in non-small cell lung cancer (NSCLC) subjects receiving full-dose anti-coagulation (FDAC) treated on protocol BO17704

✍ Leighl, N.; Bennouna, J.; Kuo, H.; Szima, B.; Gottfried, M.; Kunitsyn, A.; Trigo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Review of Pulmonary Hemorrhage (PH) in N

Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704

✍ F. LaFleur; J. Skillings; V. Hirsh; J. Bennouna; H.-P. Kuo; B. Szima; M. Gottfri 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 450 KB

6526 POSTER Review of pulmonary haemorrh

6526 POSTER Review of pulmonary haemorrhage (PH) in non-small cell lung cancer (NSCLC) subjects receiving bevacizumab and cisplatin plus gemcitabine on protocol BO17704

✍ Hirsh, V.; Bennouna, J.; Kuo, H.; Szima, B.; Gottfried, M.; Kunitsyn, A.; Trigo, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB